Paulson Wealth Management Inc. Lowers Stake in UnitedHealth Group Inc (NYSE:UNH)

Paulson Wealth Management Inc. cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 21.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,940 shares of the healthcare conglomerate’s stock after selling 519 shares during the quarter. Paulson Wealth Management Inc.’s holdings in UnitedHealth Group were worth $495,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Canton Hathaway LLC purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $36,000. Truvestments Capital LLC purchased a new stake in UnitedHealth Group in the first quarter valued at approximately $42,000. Creative Financial Designs Inc. ADV grew its holdings in UnitedHealth Group by 89.6% in the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after purchasing an additional 95 shares during the period. Financial Gravity Wealth Inc. purchased a new stake in UnitedHealth Group in the first quarter valued at approximately $58,000. Finally, Horan Capital Advisors LLC. purchased a new stake in UnitedHealth Group in the first quarter valued at approximately $68,000. Institutional investors and hedge funds own 85.87% of the company’s stock.

In other news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the transaction, the director now directly owns 187,663 shares of the company’s stock, valued at $45,412,569.37. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,000 shares of company stock valued at $7,963,620. 0.87% of the stock is owned by insiders.

UNH traded up $1.70 during trading on Friday, hitting $249.33. 1,695,304 shares of the company’s stock were exchanged, compared to its average volume of 3,999,659. The company has a current ratio of 0.67, a quick ratio of 0.73 and a debt-to-equity ratio of 0.62. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The stock’s 50 day moving average is $251.65. The stock has a market capitalization of $235.95 billion, a price-to-earnings ratio of 19.36, a P/E/G ratio of 1.32 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same period in the previous year, the firm earned $3.14 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.0% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.

A number of equities research analysts recently issued reports on UNH shares. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. UBS Group started coverage on shares of UnitedHealth Group in a report on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 target price for the company. Bank of America restated a “buy” rating and issued a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, SunTrust Banks lowered their target price on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Price-Sales Ratio

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.